Scott Ward, senior vice president and head of the cardiovascular business unit, and
Steve La Neve, senior vice president and head of the spinal and biologics unit, will leave their positions after an unspecified transition period, according to the report. Mr. Ward will leave Medtronic, while Mr. La Neve’s next move was not known.
Medtronic announced its fourth quarter results last week, which included poor performance in the spinal unit.
Read the WSJ’s report on Medtronic.
